Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct 23:3:125.
doi: 10.3389/fendo.2012.00125. eCollection 2012.

Cancer stem cells, tumor dormancy, and metastasis

Affiliations

Cancer stem cells, tumor dormancy, and metastasis

Purvi Patel et al. Front Endocrinol (Lausanne). .

Abstract

Tumor cells can persist undetectably for an extended period of time in primary tumors and in disseminated cancer cells. Very little is known about why and how these tumors persist for extended periods of time and then evolve to malignancy. The discovery of cancer stem cells (CSCs) in human tumors challenges our current understanding of tumor recurrence, drug resistance, and metastasis, and opens up new research directions on how cancer cells are capable of switching from dormancy to malignancy. Although overlapping molecules and pathways have been reported to regulate the stem-like phenotype of CSCs and metastasis, accumulated evidence has suggested additional clonal diversity within the stem-like cancer cell subpopulation. This review will describe the current hypothesis linking CSCs and metastasis and summarize mechanisms important for metastatic CSCs to re-initiate tumors in the secondary sites. A better understanding of CSCs' contribution to clinical tumor dormancy and metastasis will provide new therapeutic revenues to eradicate metastatic tumors and significantly reduce the mortality of cancer patients.

Keywords: EMT–MET cooperativity; cancer stem cells; disseminated CSCs; metastasis; stem-like subpopulations; tumor dormancy.

PubMed Disclaimer

References

    1. Bao S., Wu Q., Sathornsumetee S., Hao Y., Li Z., Hjelmeland A. B., et al. (2006). Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 66 7843–7848 - PubMed
    1. Brabletz T. (2012). To differentiate or not – routes towards metastasis. Nat. Rev. Cancer 12 425–436 - PubMed
    1. Burk U., Schubert J., Wellner U., Schmalhofer O., Vincan E., Spaderna S., et al. (2008). A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 9 582–589 - PMC - PubMed
    1. Cairns J. (2002). Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 99 10567–10570 - PMC - PubMed
    1. Cameron M. D., Schmidt E. E., Kerkvliet N., Nadkarni K. V., Morris V. L., Groom A. C., et al. (2000). Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res. 60 2541–2546 - PubMed